Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

If the CMS rule to cover obesity medications is finalized, coverage will increase by other insurers, experts predicted. HHS ...

Today's Research Daily features new research reports on 16 major stocks, including Apple Inc. (AAPL), Eli Lilly and Company ...

Hims & Hers offers a copycat of the blockbuster weight-loss drug at a fraction of the cost. But it might be a short-lived ...

Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.

About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent increase from 2023, according to a Globe analysis of insurance claims data.

Advocates say microdosing reduces costs and side effects while maintaining weight loss, then can help with weight maintenance ...

If you’re interested in learning more about Zepbound and how you can acquire it, continue reading. If you’re looking for a cost-effective option to get Zepbound online, PlushCare is worth ...

These prices do not include the cost of Zepbound, and PlushCare states that the drug can cost $1,060 per month without insurance and that the price may vary by pharmacy. You can also use the ...

Likewise, compounded tirzepatide has the identical active ingredient as Zepbound. While compounded ... individuals and the high out-of-pocket cost of products for many patients.

The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...